CeBIL symposium: Sustainable health innovation, grand challenges & the law

Minssen, T. (Arrangør)
Corrales Compagnucci, M. (Arrangør)
Maryna Pagels (Arrangør)
Verda Sigura (Arrangør)
Louise Druedahl (Arrangør)
Michelle Goncalves Kjærulff (Arrangør)
Kollmar, C. L. (Arrangør)
Suzan Duran (Arrangør)

Centeret for Avancerede Studier i Biovidenskablig Innovationsret

Aktivitet: Deltagelse i arrangement eller begivenhed - typer › Organisation af og deltagelse i konference

Beskrivelse

This symposium marks the conclusion of the Novo Nordisk Foundation’s Collaborative Research Program in Biomedical Innovation Law (the CeBIL-program), which has been running since 2018. Leading international experts will discuss the ethical, legal, and social, and policy implications (ELSPI) of selected challenges and opportunities in the health and life sciences. This event has two aims. First, it provides a forum for presenting novel insights based on the past and ongoing research conducted by the CeBIL team and their research partners. Second, this conference focuses on emerging research areas to address the Grand Challenges of the Future.

Topics that will be discussed range from sustainable innovation, pandemic preparedness, antimicrobial resistance, and biologics to advanced medical computing, artificial intelligence, orphan drugs, and repurposed drugs.

Periode	14 jun. 2023 → 15 jun. 2023
Begivenhedstype	Konference
Placering	Copenhagen, Danmark
Grad af anerkendelse	International